MetaADEDB 2.0 @ LMMD
Splenic neoplasm malignancy unspecified
(UMLS:C0948980)
UMLS ID:
C0948980
MeSH ID:
N/A
Synonym(s)
1.
Splenic neoplasm malignancy unspecified
Associated Drug(s)
NameNumber of ReportsReference(s)Data Source
1PCI 32765FAERS: 3US FAERS
2tofacitinibFAERS: 3US FAERS
3BortezomibFAERS: 2US FAERS
4Imatinib MesylateFAERS: 2US FAERS
5teriflunomideFAERS: 2US FAERS
64-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamideFAERS: 1US FAERS
7Dimethyl FumarateFAERS: 1US FAERS
8EverolimusFAERS: 1US FAERS
9GabapentinFAERS: 1US FAERS
10Glatiramer AcetateFAERS: 1US FAERS
11Mycophenolic AcidFAERS: 1US FAERS
12OctreotideFAERS: 1US FAERS
13RivastigmineFAERS: 1US FAERS
14TeriparatideFAERS: 1US FAERS
15Zoledronic AcidFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
16eltrombopagFAERS: 1US FAERS
17icatibantFAERS: 1US FAERS
18nefazodoneFAERS: 1US FAERS
19EtoposideOFFSIDES
20MaravirocOFFSIDES
21MegestrolOFFSIDES
22PyridoxalOFFSIDES
23VancomycinOFFSIDES
24loxoprofenOFFSIDES
25vogliboseOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.